Related Experiment Videos
The cubic ternary complex receptor-occupancy model. III. resurrecting efficacy
J M Weiss1, P H Morgan, M W Lutz
1Department of Statistics, North Carolina State University, Raleigh 27695, USA.
Journal of Theoretical Biology
|August 21, 1996
Summary
This study redefines pharmacological efficacy beyond simple ligand-receptor binding. It introduces potential and realized efficacy, considering receptor activation and G-protein coupling for a more nuanced understanding of drug action.
Area of Science:
- Pharmacology
- Biochemistry
- Computational Biology
Background:
- Traditional pharmacology uses affinity and efficacy (bipartite view) for receptor-ligand interactions.
- Existing efficacy models are limited, particularly for complex systems involving receptor activation and signaling.
- A more comprehensive understanding is needed for intricate pharmacological processes.
Purpose of the Study:
- To extend the concept of efficacy to models incorporating receptor activation and G-protein coupling.
- To propose a new framework distinguishing potential and realized efficacy.
- To re-evaluate the bipartite view in light of these extended concepts.
Main Methods:
- Utilized the cubic ternary complex model for analysis.
- Defined potential efficacy as a vector of part-worth utilities assigned to each receptor species.
- Defined realized efficacy as the expectation of these utilities based on receptor species distribution.
Main Results:
- Efficacy is not solely a ligand-receptor property but depends on receptor species distribution.
- Introduced potential efficacy (vector) and realized efficacy (scalar).
- Realized efficacy represents the utility of ligand binding as a random prospect.
Conclusions:
- The extended definition of efficacy provides a more accurate representation of drug action in complex systems.
- The bipartite view's limitations are highlighted, suggesting a need for revised pharmacological models.
- This framework has implications for understanding agonism and drug efficacy assessment.